Paul Tudor Jones Xencor Inc Put Options Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
213Shares Held
72.6MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$180 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$146 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$130 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$86.5 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$63.7 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $968M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...